Welcome to myfortic®

The myfortic® (mycophenolic acid) delayed-release tablet is an enteric coated formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA). This enteric coating ensures that the active moiety is delivered directly to the small intestine without being metabolized in the stomach.

myfortic® is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.

Please see Important Safety Information below. Click here for full prescribing information, including BOXED WARNINGS.

30-Day Free Trial*

Make myfortic® accessible for your patients.

Get Voucher

*Product coverage and program subject to change without notice.

myfortic patient education brochure

myfortic® Patient Brochure

Provide information about your patient’s therapy.

Download Brochure
myfortic to MMF dose converter, MPA to MMF converter, dose conversion

Dose Conversion

MMF to myfortic® in 1 easy step.

Open Converter
myfortic J Code, myfortic billing code

myfortic® J Code

J7518 (180 mg)

ISI Text full Prescribing Information